Evaluation of the black mulberry effects under the symptoms of menopause

Not Applicable

• Conditions: N95.1; Women with climacteric symptoms.Keywords: State of menopause and female climacteric, Climacteric.

• Registration Number: RBR-9t4xxk
• Lead Sponsor: Hospital Universitário da Universidade Federal do Maranhão/HU/UFMA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-05-04
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Women aged between 35 and 65 years old who present climacteric symptoms,among them hot flushes; paraesthesia; insomnia; nervousness; depression; fatigue; arthralgia; headache; palpitation and ringing in the ear

Exclusion Criteria

Women with previous or family history of breast cancer; ovarian cancer or endometrial cancer; with hepatic failure; porphyria; abnormal endometrial bleeding; deep vein thrombosis and coronary artery disease will be excluded

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement of climacteric symptoms evaluated by reduction of the Blatt-Kupperman Index after 2 months of treatment.<br>;Improvement of the quality of life evaluated by Quality of Life Questionnaire SF-36 after 2 months of treatment.

Secondary Outcome Measures

Name	Time	Method
Improvement of the lipid profile with reduction of serum values after 2 months of treatment.;Hypoglycemic effect evaluated by reduction of fasting glycemia after 2 months of treatment.;Improvement of vaginal atrophy evaluated by oncotic colpocitology after 2 months of treatment.